WellDoc BlueStar vs iPredict Eye Screening
AI Verdict
Choose WellDoc BlueStar if…
Choose WellDoc BlueStar if your organization needs a comprehensive, AI-powered digital health solution for ongoing chronic disease management across multiple cardiometabolic conditions. This tool is ideal for empowering patients with personalized coaching, integrating data from various connected devices, and providing actionable insights to care teams for improved patient outcomes.
View WellDoc BlueStar →Choose iPredict Eye Screening if…
Choose iPredict Eye Screening if your primary care clinic or telemedicine service requires a fast, non-invasive AI-based tool for early detection of retinal diseases like AMD, DR, and Glaucoma. This solution is best suited for quickly identifying at-risk patients for these conditions, as well as predicting systemic disease risk, to facilitate timely referrals and interventions.
View iPredict Eye Screening →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | WellDoc BlueStar | iPredict Eye Screening |
|---|---|---|
| Pricing | Enterprise pricing; paid by health plans, health systems, or employers. | Contact for pricing |
| Deployment | Mobile app (iOS, Android) and web-based platform | Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
WellDoc BlueStarWellDoc BlueStar offers a more comprehensive and continuous patient-centric usability experience through its mobile and web platforms, providing personalized coaching and extensive data logging for chronic disease management. This sustained engagement for patients is a broader and more impactful aspect of usability compared to the operator-focused efficiency of iPredict Eye Screening.
Clinical Value
WellDoc BlueStarWhile both tools offer significant clinical value, WellDoc BlueStar's ability to provide personalized, multi-condition chronic disease management, including insulin dose recommendations, offers a more direct and continuous impact on daily patient care and the potential for improved long-term health outcomes.
Pricing & Value
iPredict Eye ScreeningiPredict Eye Screening offers greater transparency in its pricing model, providing an estimated per-patient cost and explicitly linking it to potential payor reimbursement. This allows potential buyers to more readily assess the financial value and return on investment compared to WellDoc BlueStar's less detailed enterprise pricing.
Enterprise Readiness
WellDoc BlueStarWellDoc BlueStar explicitly states it has a Business Associate Agreement (BAA), which is a crucial component for demonstrating data security and privacy compliance in enterprise healthcare deployments. While iPredict Eye Screening offers strong integration features, the explicit BAA gives WellDoc BlueStar an edge in enterprise readiness.
Innovation
iPredict Eye ScreeningiPredict Eye Screening demonstrates a higher degree of innovation by extending the utility of retinal imaging beyond ophthalmology to predict systemic diseases like stroke and heart attack. This novel application of AI for broader health risk assessment is a more groundbreaking advancement.
Support & Docs
WellDoc BlueStarWellDoc BlueStar provides more explicit and detailed information regarding its customer support channels, including a dedicated customer care line and comprehensive FAQs for patient troubleshooting and feature utilization. iPredict Eye Screening focuses more on operational simplicity and training, with less public detail on ongoing support resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | WellDoc BlueStar | iPredict Eye Screening |
|---|---|---|
| Name | WellDoc BlueStar | iPredict Eye Screening |
| Description | FDA-cleared, AI-powered digital health solution for chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure. | FDA-cleared AI-powered screening tool for age-related macular degeneration (AMD) in patients aged 50 years and older, alongside screening for Diabetic Retinopathy (DR) and Glaucoma. The platform also provides risk prediction for systemic diseases like stroke and heart attack, integrating with EHR and telemedicine services. |
| Primary Focus / Target Conditions | Chronic disease management (diabetes, hypertension, heart failure, weight management, behavioral health). | Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), Glaucoma, and risk prediction for stroke and heart attack. |
| Key AI Functionality | AI-driven personalized coaching, insulin dose recommendations (bolus, basal, premixed). | AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma; AI-Based Telemedicine Service; Online Health Risk Prediction System for Diabetic, Stroke, and Heart Attack patients. |
| Integration Capabilities | Connected devices (BGM, CGM, BP cuffs, weight scales, activity trackers, insulin pens). | Electronic Health Record (EHR) Solutions, AI-Based Telemedicine Service. |
Videos
Demos, reviews, and walkthroughs featuring WellDoc BlueStar and iPredict Eye Screening.
Frequently Asked Questions
More Comparisons
More matchups featuring WellDoc BlueStar or iPredict Eye Screening
Backers
Who funded each tool's parent company.